RE:Mr. Hoe and 20 million sharesThanks for that info. Have not been folowing mph much the last 3-4 years it has been a dream that became a nightmare with the failed clinical trial results. I have been plesantly surprised by the major turn of events and the bounding share price.So I dream again. With some upcoming financial results and hopefully exponential growth in hospital numbers, we could shoot to the moon. Very few shares outstanding.Aggrastat has proven to be a saviour for the company. I remember a poster,who years ago was very down on the aquisition to the rights of aggrastat.
I hope you have more info about future plans for mph. What do you know about the plans (timeframe)for the transdermal patch.
By the way the gentleman`s last name that you nrefer to is Hoie. A google search yielded me this info .
``Dr. Lars Henrik Høie, M.D., Ph.D.(dr. philos.) founded Nutri Pharma ASA (alternate name: Bionor Pharma ASA) in 1993 and serves as its Chairman. Dr. Høie served as the Senior Advisor of Medical and Scientific Affairs at Nutri Pharma ASA. He has more than 15 years experience in research and clinical practice of medicine. In 1986, he co-founded the Center of Heart Medicine and the Norwegian Medical Center in Oslo, and has had formal commercial agreements with Nycomed Pharma AS since 1989. Dr. Høie is the Inventor of the various products and composition patents owned by Nutri Pharma. He is published internationally and has submitted a Ph.D. thesis to Oslo University on the treatment of obesity with low calorie diets. He has been a Director of Bionor Pharma ASA since 2011. He has also conducted studies in Statistics and Epidemiology at London University. Upon completion of his Medical degree at Aarhus University in Denmark, Dr. Høie has been conducting clinical trials on obesity and metabolic syndrome.``